Skip to content
Find an ETF
← All ETFs

Available in 10 markets

iShares MSCI Emerging Markets Value Factor ETF

iShares · US46438G2084

iShares MSCI Emerging Markets Value Factor ETF is an exchange-traded fund (ETF) from iShares, traded under the ticker EVLU (ISIN US46438G2084). It lets you buy a basket of holdings in a single trade, spreading your money across them rather than one company. In plain terms it is about owning small slices of companies, so you share in their growth when…

· Tracks the MSCI Emerging Markets Value Factor index ?
Equity ?Unknown Physical ?
Mid-range feeOwns the shares directlyEmerging Markets
Find funds like this

Opens the screener with this filter applied.

Fund size (AUM) ?
€0
1-year return ?
+40.3%
Price Return · to 2026-07-23
Yearly fee (TER) ?
0.35%
All-in cost ≈ 0.00%

About this fund

What you own

The MSCI Emerging Markets Value Factor index is the benchmark this fund aims to copy.

How it works

The fund actually buys every share in the index it tracks (full replication).

Read more

Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.

Cost

0.35%Yearly fee (TER)
0.00%All-in cost

The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.

Read more

For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.

Fund facts

Index tracked ?
MSCI Emerging Markets Value Factor
Replication ?
Physical
Full — buys every share
Launched
Sep 2024

Performance

94.9104114124133202520262026

Growth of $100 invested — both lines start at $100.

iShares MSCI Emerging Markets Value Factor ETF Average MSCI Emerging Markets Value Factor ETF (funds we track) ?

Compared with the average fund tracking the same index — our own data, not the licensed index itself.

YTD+24.9%
1 year+40.3%

How bumpy has it been?

21.1%
Volatility (1y) ?
How much the price swings year to year — lower is calmer.
-18.0%
Worst drop (3y) ?
The biggest fall from a peak over the last three years.

The bigger picture

+64.8%
Since inception
Total growth since launch — about +30.5% a year.
+67.3%
Best 12 months
The strongest one-year stretch on record.
+11.3%
Worst 12 months
The weakest one-year stretch on record.
-18.0%
Worst fall on record ?
It clawed back in about 2 months.

Where to buy this fund

Set from your language & location — change it if it's wrong.

Where it trades

ExchangeTickerCurrency
NYSEEVLUUSD★ Primary
USD listings
E1EVLUUSDUSD
EOEVLUUSDUSD
EUEVLUUSDUSD
NYSE ArcaEVLUUSD
OCEVLUUSD
ODEVLUUSD
UAEVLUUSD
UBEVLUUSD
UCEVLUUSD
UDEVLUUSD
UFEVLUUSD
UMEVLUUSD
USEVLUUSD
UTEVLUUSD
UXEVLUUSD
VFEVLUUSD
VGEVLUUSD
VJEVLUUSD
VKEVLUUSD
VLEVLUUSD
VPEVLUUSD
VYEVLUUSD
X1EVLUUSDUSD
X2EVLUUSDUSD
XAEVLUUSDUSD
XETRAEVLUUSD
XFEVLUUSDUSD
XGEVLUUSDUSD
XHEVLUUSDUSD
XJEVLUUSDUSD
XLEVLUUSDUSD
XOEVLUUSDUSD
XQEVLUUSDUSD
XTEVLUUSDUSD
XUEVLUUSDUSD
XVEVLUUSDUSD
XWEVLUUSDUSD
XXEVLUUSDUSD
XYEVLUUSDUSD
XZEVLUUSDUSD
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows

How it ranks vs peers

🪙 Cheaper than 34% of similar ETFs📈 Higher 1-yr return than 91%📊 Beat its category by 15.0% (1-yr) (category average +25.2%)

Versus the Equity (stocks) · Emerging Markets · USD ETFs we track.

Advanced risk

14.4%
Downside deviation ?
58%
Up months (hit rate) ?
$43.96
52-week high ?
$27.55
52-week low ?

Similar funds

We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.

Matched on🌍 Emerging Markets stocks
Compare side by side
6 similar funds
iShares MSCI Emerging Markets Value Factor ETFiSharesYou're viewingiShares Core MSCI EM IMI UCITS ETFiSharesBroader matchState Street® SPDR® Portfolio Emerging Markets ETFSPDRBroader matchAmundi Core MSCI Emerging Markets Swap UCITS ETF AccAmundiBroader matchUBS Core MSCI EM UCITS ETF USD disUBSBroader matchUBS Core MSCI EM UCITS ETF USD accUBSBroader matchUBS Core MSCI EM UCITS ETF USD UkdisUBSBroader match
Why it's similarThis is the fund on this page.
StocksPhysicalCheaper fee
Tracks a different index in the same category.
StocksUnknownPhysicalCheaper fee
Tracks a different index in the same category.
StocksCheaper fee
Tracks a different index in the same category.
StocksPhysicalCheaper fee
Tracks a different index in the same category.
StocksPhysicalCheaper fee
Tracks a different index in the same category.
StocksPhysicalCheaper fee
Tracks a different index in the same category.
Index trackedMSCI Emerging Markets Value FactorMSCI Emerging Markets IMIS&P Emerging BMI IndexMSCI Emerging Markets Net Total Return USD IndexMSCI EMMSCI EMMSCI EM
Yearly fee (TER)0.35%0.18%0.07%0.14%0.15%0.15%0.15%
All-in cost0.00%0.18%0.00%0.14%0.00%0.00%0.00%
Fund size€0€39B€15.6B€11.4B€11.3B€11.3B€11.3B
DomicileIrelandUnited StatesLULULULU
ReplicationPhysical (full)Physical (full)Physical (full)Synthetic (swap)Physical (full)Physical (full)Physical (full)
3-yr return p.a.+19.0%+16.3%+20.5%+24.2%+25.0%
5-yr return p.a.+7.3%+4.1%+8.0%+9.1%+8.2%
# holdings4,0082,78010101010

The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.

Open the full comparison tool →
Data as of 2026-07-23 · Source: issuer data, compiled by Finance Hamster

New to ETFs? Start with the basics →

Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.